Symbol:
SELENOM
Name:
selenoprotein M
Description:
Predicted to be involved in several processes, including corticosterone secretion; growth; and response to selenium ion. Predicted to localize to the Golgi apparatus; endoplasmic reticulum; and perinuclear region of cytoplasm.
Type:
protein-coding
RefSeq Status:
REVIEWED
Also known as:
MGC40146; selenoprotein SelM; SELM; SEPM
Orthologs:
Species
Gene symbol and name
Data Source
Assertion derived from
less info ...
Orthologs 1
Mus musculus (house mouse):
Selenom (selenoprotein M) HGNC
EggNOG, Ensembl, HomoloGene, Inparanoid, NCBI, OMA, OrthoDB, OrthoMCL, Panther, PhylomeDB, Treefam
Rattus norvegicus (Norway rat):
Selenom (selenoprotein M) HGNC
Ensembl, HomoloGene, NCBI
Chinchilla lanigera (long-tailed chinchilla):
Selenom (selenoprotein M) NCBI
Ortholog
Pan paniscus (bonobo/pygmy chimpanzee):
SELENOM (selenoprotein M) NCBI
Ortholog
Canis lupus familiaris (dog):
SELENOM (selenoprotein M) HGNC
HomoloGene, NCBI
Ictidomys tridecemlineatus (thirteen-lined ground squirrel):
Selenom (selenoprotein M) NCBI
Ortholog
Sus scrofa (pig):
SELENOM (selenoprotein M) HGNC
EggNOG, Ensembl, NCBI, OrthoDB, Treefam
Alliance orthologs 3
Rattus norvegicus (Norway rat):
Selenom (selenoprotein M)
Alliance
DIOPT (Ensembl Compara, HGNC, OMA, OrthoFinder, PANTHER)
Mus musculus (house mouse):
Selenom (selenoprotein M)
Alliance
DIOPT (Ensembl Compara, Hieranoid, InParanoid, OMA, OrthoFinder, OrthoInspector, PANTHER, PhylomeDB, Roundup, TreeFam)
Danio rerio (zebrafish):
selenom
Alliance
DIOPT (Ensembl Compara, Hieranoid, InParanoid, OMA, OrthoFinder, OrthoInspector, PANTHER, PhylomeDB, TreeFam, ZFIN)
Allele / Splice:
See ClinVar data
Latest Assembly:
GRCh38 - Human Genome Assembly GRCh38
Position:
Human Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCh38 22 31,104,777 - 31,107,568 (-) NCBI GRCh38 GRCh38 hg38 GRCh38 GRCh37 22 31,500,763 - 31,503,551 (-) NCBI GRCh37 GRCh37 hg19 GRCh37 Build 36 22 29,830,763 - 29,833,551 (-) NCBI NCBI36 hg18 NCBI36 Celera 22 15,300,895 - 15,303,683 (-) NCBI Cytogenetic Map 22 q12.2 NCBI HuRef 22 14,462,570 - 14,465,358 (-) NCBI HuRef CHM1_1 22 31,460,600 - 31,463,388 (-) NCBI CHM1_1
JBrowse:
View Region in Genome Browser (JBrowse)
Model
1-naphthyl isothiocyanate increases expression ISO RGD:1565037 6480464 1-Naphthylisothiocyanate results in increased expression of SELENOM mRNA CTD PMID:25380136 17alpha-ethynylestradiol multiple interactions ISO RGD:1622145 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SELENOM mRNA CTD PMID:17942748 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of SELENOM mRNA CTD PMID:20106945 17beta-estradiol multiple interactions EXP 6480464 [Estradiol co-treated with TGFB1 protein] results in increased expression of SELENOM mRNA CTD PMID:30165855 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of SELENOM mRNA CTD PMID:23019147 2,2',5,5'-tetrachlorobiphenyl increases expression ISO RGD:1565037 6480464 2 more ... CTD PMID:23829299 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1622145 6480464 Tetrachlorodibenzodioxin affects the expression of SELENOM mRNA CTD PMID:21570461 , PMID:24680724 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1622145 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SELENOM mRNA CTD PMID:17942748 4,4'-diaminodiphenylmethane increases expression ISO RGD:1565037 6480464 4, 4'-diaminodiphenylmethane results in increased expression of SELENOM mRNA CTD PMID:25380136 4-hydroxyphenyl retinamide increases expression ISO RGD:1622145 6480464 Fenretinide results in increased expression of SELENOM mRNA CTD PMID:28973697 6-propyl-2-thiouracil decreases expression ISO RGD:1565037 6480464 Propylthiouracil results in decreased expression of SELENOM mRNA CTD PMID:24780913 acetylsalicylic acid increases expression EXP 6480464 Aspirin results in increased expression of SELENOM mRNA CTD PMID:11906190 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of SELENOM mRNA CTD PMID:27153756 antirheumatic drug decreases expression EXP 6480464 Antirheumatic Agents results in decreased expression of SELENOM mRNA CTD PMID:24449571 Aroclor 1254 increases expression ISO RGD:1622145 6480464 Chlorodiphenyl (54% Chlorine) results in increased expression of SELENOM mRNA CTD PMID:23650126 arsane increases methylation EXP 6480464 Arsenic results in increased methylation of SELENOM promoter CTD PMID:21291286 arsenic acid decreases expression ISO RGD:1622145 6480464 arsenic acid results in decreased expression of SELENOM mRNA CTD PMID:19429247 arsenic atom increases methylation EXP 6480464 Arsenic results in increased methylation of SELENOM promoter CTD PMID:21291286 arsenite(3-) decreases expression ISO RGD:1622145 6480464 arsenite results in decreased expression of SELENOM mRNA CTD PMID:19429247 benzo[a]pyrene increases expression ISO RGD:1622145 6480464 Benzo(a)pyrene results in increased expression of SELENOM mRNA CTD PMID:22228805 bis(2-chloroethyl) sulfide increases expression EXP 6480464 Mustard Gas results in increased expression of SELENOM mRNA CTD PMID:25102026 bisphenol A decreases expression ISO RGD:1622145 6480464 bisphenol A results in decreased expression of SELENOM mRNA CTD PMID:26063408 bisphenol A decreases expression ISO RGD:1565037 6480464 bisphenol A results in decreased expression of SELENOM mRNA CTD PMID:25181051 Brodifacoum decreases expression ISO RGD:1565037 6480464 bromfenacoum results in decreased expression of SELM protein CTD PMID:28903499 butanal increases expression EXP 6480464 butyraldehyde results in increased expression of SELENOM mRNA CTD PMID:26079696 cadmium dichloride increases expression ISO RGD:1565037 6480464 Cadmium Chloride results in increased expression of SELENOM mRNA CTD PMID:25993096 choline multiple interactions ISO RGD:1622145 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of SELENOM gene CTD PMID:20938992 cyclosporin A increases expression ISO RGD:1622145 6480464 Cyclosporine results in increased expression of SELENOM mRNA CTD PMID:19770486 cyclosporin A increases expression EXP 6480464 Cyclosporine results in increased expression of SELENOM mRNA CTD PMID:20106945 cytarabine decreases expression EXP 6480464 Cytarabine results in decreased expression of SELENOM mRNA CTD PMID:21198554 dibutyl phthalate increases expression ISO RGD:1565037 6480464 Dibutyl Phthalate results in increased expression of SELENOM mRNA CTD PMID:21266533 diuron increases expression ISO RGD:1565037 6480464 Diuron results in increased expression of SELENOM mRNA CTD PMID:21551480 dorsomorphin multiple interactions EXP 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin decreases expression EXP 6480464 Doxorubicin results in decreased expression of SELENOM mRNA CTD PMID:29803840 entinostat increases expression EXP 6480464 entinostat results in increased expression of SELENOM mRNA CTD PMID:27188386 folic acid multiple interactions ISO RGD:1622145 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of SELENOM gene CTD PMID:20938992 furan increases expression ISO RGD:1565037 6480464 furan results in increased expression of SELENOM mRNA CTD PMID:27387713 L-methionine multiple interactions ISO RGD:1622145 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of SELENOM gene CTD PMID:20938992 mercury dibromide decreases expression EXP 6480464 mercuric bromide results in decreased expression of SELENOM mRNA CTD PMID:26272509 mercury dibromide multiple interactions EXP 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SELENOM mRNA CTD PMID:27188386 metacetamol decreases expression ISO RGD:1622145 6480464 3-hydroxyacetanilide results in decreased expression of SELENOM mRNA CTD PMID:18544908 N-nitrosodimethylamine increases expression ISO RGD:1565037 6480464 Dimethylnitrosamine results in increased expression of SELENOM mRNA CTD PMID:25380136 oxaliplatin multiple interactions ISO RGD:1565037 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of SELENOM mRNA CTD PMID:25729387 oxaliplatin increases expression ISO RGD:1565037 6480464 oxaliplatin results in increased expression of SELENOM mRNA CTD PMID:25729387 paracetamol affects expression ISO RGD:1622145 6480464 Acetaminophen affects the expression of SELENOM mRNA CTD PMID:17562736 paracetamol affects response to substance EXP 6480464 SELENOM gene polymorphism affects the susceptibility to Acetaminophen CTD PMID:26104854 paracetamol decreases expression ISO RGD:1622145 6480464 Acetaminophen results in decreased expression of SELENOM mRNA CTD PMID:18544908 phenylmercury acetate decreases expression EXP 6480464 Phenylmercuric Acetate results in decreased expression of SELENOM mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions EXP 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SELENOM mRNA CTD PMID:27188386 potassium chromate increases expression EXP 6480464 potassium chromate(VI) results in increased expression of SELENOM mRNA CTD PMID:22714537 SB 431542 multiple interactions EXP 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silicon dioxide decreases expression ISO RGD:1565037 6480464 Silicon Dioxide results in decreased expression of SELENOM mRNA CTD PMID:22431001 tetrachloromethane affects expression ISO RGD:1622145 6480464 Carbon Tetrachloride affects the expression of SELENOM mRNA CTD PMID:17484886 tetrachloromethane increases expression ISO RGD:1622145 6480464 Carbon Tetrachloride results in increased expression of SELENOM mRNA CTD PMID:27339419 thapsigargin increases expression EXP 6480464 Thapsigargin results in increased expression of SELM mRNA CTD PMID:29453283 topotecan multiple interactions ISO RGD:1565037 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of SELENOM mRNA CTD PMID:25729387 topotecan increases expression ISO RGD:1565037 6480464 Topotecan results in increased expression of SELENOM mRNA CTD PMID:25729387 trichostatin A decreases expression EXP 6480464 trichostatin A results in decreased expression of SELENOM mRNA CTD PMID:26272509 trichostatin A multiple interactions EXP 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SELENOM mRNA CTD PMID:27188386 tungsten decreases expression ISO RGD:1622145 6480464 Tungsten results in decreased expression of SELM mRNA CTD PMID:30912803 tunicamycin increases expression EXP 6480464 Tunicamycin results in increased expression of SELENOM mRNA CTD PMID:22378314 valproic acid affects expression EXP 6480464 Valproic Acid affects the expression of SELENOM mRNA CTD PMID:25979313 valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of SELENOM mRNA, Valproic Acid results in increased expression of SELM mRNA CTD PMID:23179753 more ... vinclozolin decreases expression ISO RGD:1565037 6480464 vinclozolin results in decreased expression of SELENOM mRNA CTD PMID:23034163 
Gene-Chemical Interaction Annotations
